Skip to the page

Data / Crowdfunding / Oregon / Enosi Life Sciences Corp.

Enosi Life Sciences Corp.: crowdfunding raise on Title3Funds, $100,000 to $1,070,000 (2021)

Enosi Life Sciences Corp., a corporation in Eugene, OR, filed a Form C with the SEC on July 20, 2021 to raise $100,000 to $1,070,000 in common stock through Title3Funds. The offering closed on July 19, 2022. In its most recent fiscal year it reported $0 in revenue and a net loss of $1,068,482, with 4 employees.

SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.

Website
www.enosi-life.com
Funding portal
Title3Funds
Address
590 Pearl Street Suite 311, Eugene, OR 97401
Legal form
Corporation
Jurisdiction
DE
Incorporated
January 16, 2020
SEC CIK
0001822263

Offering terms

From the offering filed July 20, 2021.

Security
Common Stock
Price
$10.00
Target
$100,000
Maximum
$1,070,000
Deadline
July 19, 2022
Portal compensation
7.0%

Financials

From the Form C filed July 20, 2021.

Most recent fiscal yearPrior fiscal yearSource
Revenue$0$0sec.gov
Cost of goods sold$0$0sec.gov
Net income$-1,068,482$-397,306sec.gov
Taxes paid$0$0sec.gov
Total assets$1,341,234$1,187,974sec.gov
Cash$161,839$578sec.gov
Accounts receivable$0$0sec.gov
Short-term debt$50,425$319,955sec.gov
Long-term debt$53,667$45,401sec.gov

Filings

FiledFilingTargetMaximumDeadlineNoteSource
July 20, 2021Offering$100,000$1,070,000July 19, 2022sec.gov

All filings on sec.gov

Updated July 20, 2021. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.